Echocardiographic validation of pulmonary hypertension due to heart failure with reduced ejection fraction in mice
Autor: | Jonathan Ledoux, Yanfen Shi, Jocelyn Dupuis, Mégane Tanguay, Nour R. Dayeh, Jean-Claude Tardif |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2018 |
Předmět: |
0301 basic medicine
Male medicine.medical_specialty Heart Ventricles Hypertension Pulmonary Group ii lcsh:Medicine 030204 cardiovascular system & hematology Article 03 medical and health sciences Mice 0302 clinical medicine Internal medicine Medicine Animals Humans lcsh:Science Heart Failure Multidisciplinary Ejection fraction business.industry lcsh:R Stroke Volume Stroke volume medicine.disease Pulmonary hypertension Pathophysiology Disease Models Animal 030104 developmental biology Blood pressure Echocardiography Heart failure Correlation analysis Cardiology Female lcsh:Q business |
Zdroj: | Scientific Reports, Vol 8, Iss 1, Pp 1-11 (2018) Scientific Reports |
ISSN: | 2045-2322 |
DOI: | 10.1038/s41598-018-19625-2 |
Popis: | Pulmonary hypertension (PH) associated with left heart diseases is the most prevalent cause of PH. The scarcity of studies exploring the pathophysiology and therapies of group II PH resides in the lack of validated small animal models with non-invasive determination of the presence and severity of PH. Heart failure (HF) was induced in mice by coronary artery ligation. Mice developed PH as evidenced by an elevated right ventricular (RV) systolic pressure and RV hypertrophy. Detailed non-invasive echocardiographic analysis on the left and right ventricles showed impaired left ventricular (LV) systolic and diastolic function. In addition, RV hypertrophy was confirmed by echo and accompanied by impaired function as well as increased pulmonary resistance. Correlation analysis validated the use of the LV wall-motion score index (WMSI) at a threshold value of ≥2.0 as a powerful and reliable indicator for the presence of PH and RV dysfunction. Echocardiography is an accurate non-invasive technique to diagnose PH in a HF mouse model. Moreover, an echocardiographic parameter of infarct size and LV function, the LV WMSI, reliably correlates with the presence of PH, RV hypertrophy and RV dysfunction and could be used to improve efficiency and design of pre-clinical studies. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |